Latest News Releases From The Newsroom
FTC Sues Amazon for Illegally Maintaining Monopoly Power
September 27th, 2023
Amazon’s ongoing pattern of illegal conduct blocks competition, allowing it to wield monopoly power to inflate prices, degrade quality, and stifle innovation for consumers and businesses Washington D.C. / CRWE PRESS RELEASE / September 26, 2. Read more
Bullish View On Blink Charging; Pfizer Deal Boosts Ginkgo Bioworks
September 27th, 2023
UBS has initiated coverage on Blink Charging Co. (Nasdaq: BLNK), a leading provider of electric vehicle charging services, with a Buy rating and a price target of $7. With $BLNK closing at $2.93 on Tuesday, the price target suggests a significant . Read more
Galecto Seeks Strategic Options; Palantir Lands $250M Army Contract
September 26th, 2023
Shares of Galecto, Inc. (Nasdaq: GLTO) surged by more than 30% in after-hous trading following the company's announcement of a comprehensive review of its business operations. Galecto aims to explore strategic alternatives focused on maximizing sh. Read more
MillerKnoll Beats Wall Street Forecasts; Rocket Lab Lowers Outlook
September 26th, 2023
MillerKnoll, Inc. (Nasdaq: MLKN) reported robust first-quarter fiscal 2024 earnings, coming in at $0.37 per share, surpassing the consensus EPS estimate of $0.21. The company also exceeded revenue expectations, with quarterly sales reaching $917.70 m. Read more
PWS Study Data Boost Soleno Therapeutics; Bullish View on Fisker
September 26th, 2023
Shares of Soleno Therapeutics, Inc. (Nasdaq: SLNO) soared over 300% in pre-market trading following the release of positive top-line results from Study C602. The study, which focused on the long-term treatment of Prader-Willi syndrome (PWS) . Read more
Immunovant's IMVT-1402 Data Sparks Momentum; Ferguson Outperforms Estimates
September 26th, 2023
Shares of Immunovant, Inc. (Nasdaq: IMVT) surged by more than 40% in pre-market trading after promising Phase 1 trial results for IMVT-1402. Administered subcutaneously in healthy adults, IMVT-1402 demonstrated significant dose-dependent reductions i. Read more
Breaking: FDA Greenlights Profound Medical's TULSA AI Module
September 26th, 2023
Shares of Profound Medical Corp. (Nasdaq: PROF) surged by more than 10% in after-hours trading after it announced FDA clearance for its Thermal Boost module in conjunction with TULSA-PRO, which allows surgeons to treat various prostate conditions, in. Read more
FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates
September 25th, 2023
Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment. Read more
Crown Equity Holdings, Inc. Files Registration Statement on Form S-1 for Proposed Public Offering of its Common Stock
September 25th, 2023
LAS VEGAS, NV / CRWE PRESS RELEASE / September 25, 2023 - Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a pro. Read more
Breaking: European Commission Rebuffs Booking's eTraveli Deal
September 25th, 2023
The European Commission has put a halt to Booking Holdings Inc.'s (Nasdaq: BKNG) proposed acquisition of Flugo Group Holdings AB (eTraveli) under the EU Merger Regulation. This decision comes after an in-depth investigation, which revealed that th. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login